Señales en vivo de REPH | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (22 mar 2022 @ 00:00):

Stats
Volumen de hoy	137 536
Volumen promedio	128 488
Capitalización de mercado	177.42M
EPS	$-0.0000600 ( 2023-03-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.04
ATR14	$0.0920 (4.40%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-02	Lake Ryan David	Sell	1 419	Common Stock
2023-12-15	Lake Ryan David	Sell	5 690	Common Stock
2023-11-30	Lake Ryan David	Sell	1 197	Common Stock
2023-10-31	Lake Ryan David	Sell	1 198	Common Stock
2023-09-30	Lake Ryan David	Sell	1 198	Common Stock

INSIDER POWER
94.69
Last 95 transactions
Buy: 16 300 004 \| Sell: 826 395

Volumen Correlación

Largo: -0.07 (neutral)

Corto: 0.64 (weak)

Signal:(67.783) Neutral

Recro Pharma Inc Correlación

10 Correlaciones Más Positivas
CNDT	0.875
EGBN	0.874
ANNX	0.87
FEYE	0.863
CYXT	0.863
FNWB	0.861
DCOMP	0.858
FFWM	0.852
ATHA	0.846
BWBBP	0.843

10 Correlaciones Más Negativas
NRDS	-0.898
SGTX	-0.876
NVTS	-0.859
PESI	-0.851
MORF	-0.848
WVVI	-0.844
BTBD	-0.839
FTIV	-0.837
INOD	-0.836
AMRB	-0.835

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Recro Pharma Inc Correlación - Moneda/Commodity

0.43
( neutral )

0.42
( neutral )

0.00
( neutral )

0.50
( neutral )

0.04
( neutral )

-0.50
( neutral )

Recro Pharma Inc Finanzas

Annual	2023
Ingresos:	$94.64M
Beneficio Bruto:	$18.14M (19.17 %)
EPS:	$-0.000100

FY	2023
Ingresos:	$94.64M
Beneficio Bruto:	$18.14M (19.17 %)
EPS:	$-0.000100

FY	2022
Ingresos:	$90.21M
Beneficio Bruto:	$23.14M (25.65 %)
EPS:	$-0.340

FY	2021
Ingresos:	$75.36M
Beneficio Bruto:	$19.82M (26.30 %)
EPS:	$-0.221

Financial Reports:

No articles found.

Recro Pharma Inc

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.